Skip to main content

darunavir

Generic: DARUNAVIR·Brand: DARUNAVIR, PREZISTA, Prezcobix, Prezista, Symtuza

darunavir: 2 clinical trials tracked.

darunavir evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about darunavir, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 0 study sponsors

Related indications

HIV Infections

Study sponsors

No additional listed-company sponsor is linked.

Clinical Trial Registry Records (2)

Management Using the Latest Technologies in Resource-limited Settings to Optimize Combination Therapy After Viral Failure (MULTI-OCTAVE)

NCT01641367Registry updated 2019-03-15·Phase 4
Completed

Primary endpoint: Proportion of Participants With Plasma HIV-1 RNA ≤200 Copies/mL at 48 Weeks

InterventionalRandomizedopen545 enrolledStarted 2013-02Completion 2018-1219 sites · Brazil, Haiti, India, Kenya…Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

A Randomized Multicenter Study With Non-inferiority Hypothesis, Comparing the Availability to Maintain a Complete Viral Suppression by a Monotherapy of Darunavir/r to a NRTI Containing Regimen Including Darunavir/r, in HIV-1 Infected Patients With Previous Prolonged Complete Viral Suppression. ANRS 136 MONOI

NCT00421551Registry updated 2026-04-07·Phase 3
Completed

Primary endpoint: Proportion of patients with virological success, the virological failure is defined as 2 consecutive plasma viral load measurements greater or equal to 400 cp/ml within 2 weeks at W48

InterventionalRandomizedopen225 enrolledStarted 2007-03Completion 2011-021 site · FranceFrench National Agency for Research on AIDS and Viral Hepatitis